Add to a list

Inactive Instrument

Carmat Share Price Other OTC

FR0010907956

Medical Equipment, Supplies & Distribution

OTC Markets Traded

Analysts' recommendations: Carmat

09/05/25	Carmat: Invest Securities raises target price
11/04/25	Carmat: Invest Securities still a buyer, but cuts TP
04/02/25	Carmat: Invest Securities slightly lowers its target
09/01/25	Carmat: Invest Securities upgrades to buy
09/01/25	Carmat: Oddo BHF reduces its price target

More recommendations

News in other languages: Carmat

03-04	Carmat, Ynsect… quand les pépites industrielles françaises tombent dans le gouffre de Moore
01-07	Pluxee N : Carmat, Hoffmann, LDC, Pluxee, Technip Energies... les valeurs à suivre aujourd'hui à Paris
01-07	Bourse : GTT et Technip Energy engrangent, Pluxee publie, Carmat disparaît
01-07	CARMAT : A suivre aujourd'hui
01-07	Les records continuent à tomber en bourse

More news

Managers and Directors: Carmat

Manager	Title	Age	Since
Stéphane Piat CEO	Chief Executive Officer	55	31/08/2016
Pascale d’Arbonneau DFI	Director of Finance/CFO	-	11/12/2018
Christian Latrémouille CTO	Chief Tech/Sci/R&D Officer	-	31/03/2025

Director	Title	Age	Since
Pierre Bastid CHM	Chairman	71	24/06/2024
Florent Battistella BRD	Director/Board Member	63	06/05/2021
Michael Mack BRD	Director/Board Member	79	19/04/2017

More insiders

Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

The best tools reserved for subscribers to boost the performance of your investments!

Market Cap	6.15M 7.1M 5.74M 5.26M 9.9M 676M 10.05M 67.26M 26.4M 339M 26.67M 26.09M 1.12B	P/E 2023	-3.09x	P/E 2024	-0.95x
Enterprise Value	59.25M 68.46M 55.33M 50.75M 95.46M 6.52B 96.86M 648M 254M 3.27B 257M 252M 10.81B	EV / Sales 2023	56.1x	EV / Sales 2024	13.5x
Free-Float	89.06%	Yield 2023 *	-	Yield 2024	-

01-07	Carmat, Hoffmann, LDC, Pluxee, Technip Energies... Stocks to Watch Today in Paris
01-07	CARMAT: To Watch Today
01-06	Carmat, GTT, Genfit, LDC... Stocks to Watch Tomorrow in Paris
01-06	Carmat Announces Liquidation and Delisting
12-02	Only Takeover Bid for Carmat Approved by Court
12-02	Carmat: Takeover Offer Approved, 88 Jobs Saved	RE
12-02	Carmat receives takeover bid	RE
11-04	Carmat SAS submits bid for Carmat SA within ongoing receivership procedure	RE
15/10/25	CAC 40 Surges on LVMH Results and Easing US-China Tensions
15/10/25	Carmat: Judicial Recovery Continues, New Hearing Set for November 25	RE
15/10/25	Carmat says liquidation review postponed until Nov 25	RE
01/10/25	Carmat: Judicial Liquidation Request to Be Reviewed on October 14	RE
01/10/25	Carmat: Judiciary administrator has submitted request to convert receivership into liquidation to court	RE

12-02	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
11-04	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
29/10/25	CARMAT : Inside Information / Other news releases	PU
29/10/25	CARMAT Announces Postponing the Publication of its 2025 Interim Financial Report (Six Months Ended June 30, 2025)	BU
15/10/25	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CARMAT	-.--%	-.--%	-	-	7.08M
STRYKER CORPORATION	+0.47%	+4.09%	-10.21%	+20.08%	130B
SMITH & NEPHEW PLC	+1.37%	-3.93%	-16.97%	+0.27%	12.63B
GLAUKOS CORPORATION	+5.28%	+7.98%	+112.66%	+140.73%	10.61B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+2.59%	-3.43%	-42.66%	-67.38%	4.7B
DOUBLE MEDICAL TECHNOLOGY INC.	+2.93%	+3.12%	-24.17%	+41.20%	2.7B
INSPIRE MEDICAL SYSTEMS, INC.	+2.16%	+19.82%	-23.98%	-75.44%	1.74B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	+2.82%	+0.80%	-15.13%	-12.55%	1.69B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	+2.16%	-0.93%	-33.76%	-28.67%	1.66B
Average	+2.20%	+3.66%	-6.78%	+2.28%	20.72B
Weighted average by Cap.	+1.01%	+3.66%	-4.44%	+22.34%

	2023	2024
Net sales	3.84M 4.43M 3.58M 3.29M 6.18M 422M 6.27M 41.99M 16.48M 212M 16.65M 16.29M 700M	7.34M 8.49M 6.86M 6.29M 11.83M 808M 12.01M 80.38M 31.54M 405M 31.87M 31.18M 1.34B
Net income	-53.87M -62.25M -50.31M -46.14M -86.8M -5.93B -88.07M -590M -231M -2.97B -234M -229M -9.83B	-51.4M -59.39M -48M -44.02M -82.81M -5.65B -84.02M -563M -221M -2.84B -223M -218M -9.38B
Net Debt	49.64M 57.36M 46.36M 42.52M 79.98M 5.46B 81.15M 543M 213M 2.74B 215M 211M 9.05B	53.1M 61.36M 49.59M 45.48M 85.56M 5.84B 86.81M 581M 228M 2.93B 230M 225M 9.69B

Carmat Share Price Other OTC

Stocks

FR0010907956

Medical Equipment, Supplies & Distribution

Valuation: Carmat

Latest news : Carmat

Analysts' recommendations: Carmat

Press Releases: Carmat

News in other languages: Carmat

Managers and Directors: Carmat

Medical Devices & Implants

Financials

Company Profile